Claritev (NYSE: CTEV) revenue
Claritev reported revenue of $965.4m for fiscal 2025, 3.7% more than in fiscal 2024 ($930.6m). Since fiscal 2019 its revenue has fallen by 1.8%, an average decline of 0.3% a year.
Claritev's best year of the last 7 was fiscal 2021. The biggest drop was in fiscal 2023, −10.9%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $965.4m | +3.7% | $28.8m | 3.0% |
| 2024 | $930.6m | −3.2% | −$1,390m | −149.4% |
| 2023 | $961.5m | −10.9% | $162.0m | 16.8% |
| 2022 | $1,080m | −3.4% | −$362.7m | −33.6% |
| 2021 | $1,118m | +19.2% | $386.1m | 34.5% |
| 2020 | $937.8m | −4.6% | −$131.8m | −14.1% |
| 2019 | $982.9m | — | $368.2m | 37.5% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Claritev revenue compared with its sector
By revenue for its latest fiscal year, Claritev ranks 151st of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Claritev, 3.7%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 149th | InnovAge | $989.7m | 15.9% |
| 150th | Guardant Health | $982.0m | 32.9% |
| 151st | Claritev | $965.4m | 3.7% |
| 152nd | Madrigal Pharmaceuticals | $958.4m | 432.1% |
| 153rd | Pennant Group | $947.7m | 36.3% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Claritev
- How much revenue did Claritev make in fiscal 2025?
- Claritev reported revenue of $965.4m for fiscal 2025, compared with $930.6m in fiscal 2024.
- How much has the revenue of Claritev fallen?
- Between fiscal 2019 and fiscal 2025 it went from $982.9m to $965.4m: 1.8% less, an average decline of 0.3% a year.
- What was the best year for revenue at Claritev?
- Of its last 7 fiscal years, fiscal 2021, with $1,118m.
- Where does Claritev rank in its sector by revenue?
- It ranks 151st of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Claritev come from?
- From the annual report (Form 10-K) that Claritev files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Claritev files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019. More on Claritev: the Claritev page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.